N-{5-[5-(2,4-Dioxo-1,3,8-triazaspiro[4.5]dec-8-yl)pentanoyl]-2,4-dimethoxyphenyl}-4-(trifluoromethyl)benzenesulfonamide

185376-97-0

Benzenesulfonamide, N-[5-[5-(2,4-dioxo-1,3,8-triazaspiro[4.5]dec-8-yl)-1-oxopentyl]-2,4-dimethoxyphenyl]-4-(trifluoromethyl)-

N-[5-[5-(2,4-Dioxo-1,3,8-triazaspiro[4.5]dec-8-yl)-1-oxopentyl]-2,4-dimethoxyphenyl]-4-(trifluoromethyl)benzenesulfonamide

N-{5-[5-(2,4-Dioxo-1,3,8-triazaspiro[4.5]dec-8-yl)pentanoyl]-2,4-dimethoxyphenyl}-4-(trifluormethyl)benzolsulfonamid

N-{5-[5-(2,4-Dioxo-1,3,8-triazaspiro[4.5]dec-8-yl)pentanoyl]-2,4-dimethoxyphenyl}-4-(trifluoromethyl)benzenesulfonamide

N-{5-[5-(2,4-Dioxo-1,3,8-triazaspiro[4.5]déc-8-yl)pentanoyl]-2,4-diméthoxyphényl}-4-(trifluorométhyl)benzènesulfonamide

5-hydroxytryptamine receptor 1A

5-hydroxytryptamine receptor 2A

5-hydroxytryptamine receptor 2B

5-hydroxytryptamine receptor 2C

5-hydroxytryptamine receptor 3A

5-hydroxytryptamine receptor 7

5HT1A_RAT

5HT2A_HUMAN

5HT2A_RAT

5HT2B_HUMAN

5HT2C_HUMAN

5HT2C_MOUSE

5HT2C_RAT

5HT3A_MOUSE

5HT7R_CAVPO

A0A4Y6F0G0_RABIT

ACM1_RAT

ACM2_RAT

ACM3_RAT

ADA1B_RAT

ADA2B_RAT

ADRB2_RAT

GBRA1_RAT

Glutamate receptor 3

Glutamate receptor ionotropic, NMDA 1

GRIA3_RAT

Muscarinic acetylcholine receptor M1

Muscarinic acetylcholine receptor M2

Muscarinic acetylcholine receptor M3

N-[5-[5-(2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl)-1-oxopentyl]-2,4-dimethoxyphenyl]-4-(trifluoromethyl)benzenesulfonamide

N-[5-[5-(2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl)pentanoyl]-2,4-dimethoxyphenyl]-4-(trifluoromethyl)benzenesulfonamide

N-{5-[5-(2,4-Dioxo-1,3,8-triaza-spiro[4.5]dec-8-yl)-pentanoyl]-2,4-dimethoxy-phenyl}-4-trifluoromethyl-benzenesulfonamide

NK1R_HUMAN

NMDZ1_RAT

OPRK_CAVPO

OPRM_CAVPO

Q5ZQK3_RABIT

RS 102221 hydrochloride

RS-102,221

Substance-P receptor

α-1B adrenergic receptor

α-2A adrenergic receptor

α-2B adrenergic receptor

β-1 adrenergic receptor

β-2 adrenergic receptor

κ-type opioid receptor

μ-type opioid receptor